Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Prothena Corp Public (PRTA) over the last 13 years, with Q3 2025 value amounting to $10.5 million.

  • Prothena Corp Public's Accounts Payables rose 167.47% to $10.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year increase of 167.47%. This contributed to the annual value of $7.8 million for FY2024, which is 6939.86% down from last year.
  • Per Prothena Corp Public's latest filing, its Accounts Payables stood at $10.5 million for Q3 2025, which was up 167.47% from $12.2 million recorded in Q2 2025.
  • Prothena Corp Public's Accounts Payables' 5-year high stood at $25.4 million during Q4 2023, with a 5-year trough of $3.5 million in Q3 2021.
  • For the 5-year period, Prothena Corp Public's Accounts Payables averaged around $10.8 million, with its median value being $9.8 million (2022).
  • As far as peak fluctuations go, Prothena Corp Public's Accounts Payables soared by 18102.21% in 2022, and later crashed by 6939.86% in 2024.
  • Quarter analysis of 5 years shows Prothena Corp Public's Accounts Payables stood at $3.7 million in 2021, then surged by 151.15% to $9.3 million in 2022, then soared by 173.91% to $25.4 million in 2023, then plummeted by 69.4% to $7.8 million in 2024, then soared by 35.17% to $10.5 million in 2025.
  • Its Accounts Payables stands at $10.5 million for Q3 2025, versus $12.2 million for Q2 2025 and $16.0 million for Q1 2025.